---
title: "美國銀行證券重申了對 RELX plc（RLXXF）的買入評級"
description: "根據 TipRanks 的數據，Amiras 在 10041 名分析師中排名第 3288。目前，市場對 RELX plc 的分析師共識為強烈買入，平均目標價為 58.26 美元，較當前水平有 28.04% 的上漲空間。在今天發佈的一份報告中，摩根士丹利也對該股票給予了買入評級，目標價為 40.00 英鎊"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/261560639.md"
published_at: "2025-10-17T06:45:32.000Z"
---

# 美國銀行證券重申了對 RELX plc（RLXXF）的買入評級

> 根據 TipRanks 的數據，Amiras 在 10041 名分析師中排名第 3288。目前，市場對 RELX plc 的分析師共識為強烈買入，平均目標價為 58.26 美元，較當前水平有 28.04% 的上漲空間。在今天發佈的一份報告中，摩根士丹利也對該股票給予了買入評級，目標價為 40.00 英鎊

根據 TipRanks 的數據，Amiras 在 10041 名分析師中排名第 3288 位。

目前，分析師對 RELX plc 的共識評級為強烈買入，平均目標價為 58.26 美元，比當前水平有 28.04% 的上漲空間。在今天發佈的一份報告中，摩根士丹利也對該股票給予了買入評級，目標價為 40.00 英鎊。

### Related Stocks

- [RELX.US - RELX PLC](https://longbridge.com/zh-HK/quote/RELX.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| REG - RELX PLC - Director/PDMR Shareholding | RELX PLC announced changes in director shareholdings. CEO Erik Engstrom increased his holdings to 1,327,129 shares, whil | [Link](https://longbridge.com/zh-HK/news/276101908.md) |
| REG - RELX PLC - Transaction in Own Shares | RELX PLC has announced the purchase of 1,800,000 ordinary shares at an average price of 2204.32 pence each through UBS A | [Link](https://longbridge.com/zh-HK/news/276255850.md) |
| Citi Reaffirms Their Buy Rating on British American Tobacco (BATS) | Citi analyst Simon Hales has reaffirmed a Buy rating on British American Tobacco (BATS) with a price target of £49.00. H | [Link](https://longbridge.com/zh-HK/news/276060370.md) |
| New regulations for pedicabs to curb ‘rip-off’ fares | New regulations for pedicabs in London will be implemented to prevent overcharging and noise disturbances. Proposed by T | [Link](https://longbridge.com/zh-HK/news/276228755.md) |
| Citi Reaffirms Their Buy Rating on BP p.l.c. (BP) | Citi analyst Alastair Syme has reaffirmed a Buy rating on BP p.l.c. with a price target of £5.25. Syme, a 5-star analyst | [Link](https://longbridge.com/zh-HK/news/276058830.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。